dc.contributor.author
Choi, In Young
dc.contributor.author
Piccio, Laura
dc.contributor.author
Childress, Patra
dc.contributor.author
Bollman, Bryan
dc.contributor.author
Ghosh, Arko
dc.contributor.author
Brandhorst, Sebastian
dc.contributor.author
Suarez, Jorge
dc.contributor.author
Michalsen, Andreas
dc.contributor.author
Cross, Anne H.
dc.contributor.author
Morgan, Todd E.
dc.contributor.author
Wei, Min
dc.contributor.author
Paul, Friedemann
dc.contributor.author
Bock, Markus
dc.contributor.author
Longo, Valter D.
dc.date.accessioned
2018-06-08T04:06:08Z
dc.date.available
2016-07-13T10:41:22.518Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/16578
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-20759
dc.description.abstract
Summary Dietary interventions have not been effective in the treatment of
multiple sclerosis (MS). Here, we show that periodic 3-day cycles of a fasting
mimicking diet (FMD) are effective in ameliorating demyelination and symptoms
in a murine experimental autoimmune encephalomyelitis (EAE) model. The FMD
reduced clinical severity in all mice and completely reversed symptoms in 20%
of animals. These improvements were associated with increased corticosterone
levels and regulatory T (Treg) cell numbers and reduced levels of pro-
inflammatory cytokines, TH1 and TH17 cells, and antigen-presenting cells
(APCs). Moreover, the FMD promoted oligodendrocyte precursor cell regeneration
and remyelination in axons in both EAE and cuprizone MS models, supporting its
effects on both suppression of autoimmunity and remyelination. We also report
preliminary data suggesting that an FMD or a chronic ketogenic diet are safe,
feasible, and potentially effective in the treatment of relapsing-remitting
multiple sclerosis (RRMS) patients (NCT01538355).
en
dc.rights.uri
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and
Multiple Sclerosis Symptoms
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
Cell Reports. - 15 (2016), 10, S. 2136-2146
dcterms.bibliographicCitation.doi
10.1016/j.celrep.2016.05.009
dcterms.bibliographicCitation.url
http://www.sciencedirect.com/science/article/pii/S2211124716305769
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000024996
refubium.note.author
Der Artikel wurde in einer Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000006769
dcterms.accessRights.openaire
open access